| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000023739 |
| Receipt No. | R000027189 |
| Scientific Title | Distribution of mucosal microbiota: prospective research |
| Date of disclosure of the study information | 2016/11/01 |
| Last modified on | 2020/02/28 (Ver. 9) |
| Basic information | ||
| Public title | Distribution of mucosal microbiota: prospective research | |
| Acronym | Distribution of mucosal microbiota: prospective research | |
| Scientific Title | Distribution of mucosal microbiota: prospective research | |
| Scientific Title:Acronym | Distribution of mucosal microbiota: prospective research | |
| Region |
|
|
| Condition | |||
| Condition | The patients who are endoscopically normal. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To research the distribution of microbiota on the endoscopically normal mucosa of digestive tract from intraoral through proctodeum |
| Basic objectives2 | Others |
| Basic objectives -Others | Investigation of physiological distribution with microbiota |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Determination of mucosal micorobiota on digestive tract |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | endoscopically normal patients regardless of underlying disease | |||
| Key exclusion criteria | Patients with endoscopically visible lesion
Patients taking antibiotics within 4 weeks |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kyoto Prefectural University of Medicine | ||||||
| Division name | Molecular Gastroenterology and Hepatology | ||||||
| Zip code | 6028566 | ||||||
| Address | 465 Kajiicho Hirokoji Kawaramachi-dori, Kamigyo-ku, Kyoto, Japan | ||||||
| TEL | 075-251-5111 | ||||||
| ynaito@koto.kpu-m.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kyoto Prefectural University of Medicine | ||||||
| Division name | Molecular Gastroenterology and Hepatology | ||||||
| Zip code | 6028566 | ||||||
| Address | 465 Kajiicho Hirokoji Kawaramachi-dori, Kamigyo-ku, Kyoto, Japan | ||||||
| TEL | 075-251-5111 | ||||||
| Homepage URL | |||||||
| k-uchi@koto.kpu-m.ac.jp | |||||||
| Sponsor | |
| Institute | Kyoto Prefectural University of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Science and Technology Agency |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kyoto Prefectural University of Medicine Secretariat of Judding Committee |
| Address | 465 Kajiicho Hirokoji Kawaramachi-dori, Kamigyo-ku, Kyoto, Japan |
| Tel | 075-251-5337 |
| rinri@koto.kpu-m.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://www.f.kpu-m.ac.jp/k/syokanai/ |
| Publication of results | Partially published |
| Result | |||||||
| URL related to results and publications | https://doi.org/10.1159/000496102 | ||||||
| Number of participants that the trial has enrolled | 17 | ||||||
| Results | Collecting mucosa samples by brushing provided sufficient material for mucosa-associated microbiota (MAM) profiling without causing adverse effects. The upper and lower gut MAM profiles differed significantly (p < 0.0001). In the upper and lower gut, the intra- and inter-individual MAM profiles were significantly different (p = 0.0008 and p < 0.0001 respectively). |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | The volunteers were between 21 and 70 years of age. They had normal mucosa without inflammation or carcinoma. Moreover, they did not use antibiotics, proton-pump inhibitors (PPIs), probiotics, or other medications that could potentially affect the varieties of gut microbiota during 3 months prior to examination, |
||||||
| Participant flow | Under endoscopic examination, the samples, from the mid-esophagus to the rectum, were collected by the gentle brushing of each anatomical site of the mucosa 7-10 times with Cytology brush (Cook Medical, Bloomington, IN, USA, No. CCB-7-240-3-5). The swab, HydraFlock 6 (Puritan, Guilford, ME, USA, No. 25-3406H), was used for intraoral MAM sampling because it could gently scratch the intraoral mucosa. |
||||||
| Adverse events | None. |
||||||
| Outcome measures | a- and b-Diversity of MAM in gut mucosa samples. |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | We will investigate the distribution of microbiota on the endoscopically normal mucosa of digestive tract (intraoral, esophagus, stomach, duodenum, jejunum, ileum, cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum) by 16S rRNA metagenomics using brush sample collection. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027189 |